The many NO's to the use of class I antiarrhythmics: does this also apply to ethacizinum?

Back

EHRA Premium Access

The many NO's to the use of class I antiarrhythmics: does this also apply to ethacizinum?

Session: Miscellaneous aspects in arrhythmias care

Topic: Antiarrhythmic Drug Treatment

Speaker: Doctor E. Sokolova (Riga, LV)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Emma Sokolova

Riga Stradins University, Riga (Latvia)

0 follower

6 more presentations in this session

Management of rhythm and conduction disorders in cardiac amyloidosis: a French nationwide Delphi study

Speaker: Professor C. Guenancia (Dijon, FR)

Physician workload related to ILR false alarms in the era of telemedicine

Speaker: Doctor L. Cocchiara (Naples, IT)

Digital health in the EP lab: evaluating the safety and feasibility of routine implementation of remote access and technical support in complex ablation procedures - results of the REMOTE study

Speaker: Doctor S. Popescu (Luebeck, DE) Ms B. Botezat (Luebeck, DE)

The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study

Speaker: Assistant Professor Y. Yilancioglu (Izmir, TR)

Arrhythmogenic effects and cardioprotective effects of dapagliflozin against radiotherapy induced cardiac damage

Speaker: Miss S. Ulusan (Isparta, TR) Doctor M. Uzun (Kutahya, TR)

Access the full session

Miscellaneous aspects in arrhythmias care

Speakers: Doctor E. Sokolova, Professor C. Guenancia, Doctor L. Cocchiara, Doctor S. Popescu, Ms B. Botezat...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources